Literature DB >> 9209649

The role of eosinophils in the pathobiology of Hodgkin's disease.

A Pinto1, D Aldinucci, A Gloghini, V Zagonel, M Degan, V Perin, M Todesco, A De Iuliis, S Improta, C Sacco, V Gattei, H J Gruss, A Carbone.   

Abstract

BACKGROUND: Even though the presence of a prominent tissue eosinophilia represents a common histopathologic feature of Hodgkin's disease (HD), eosinophils have been mainly regarded as 'innocent' bystanders recruited and activated during the cellular reaction typical of HD. To evaluate the putative role of eosinophils or eosinophil-derived cytokines on tumor-cell regulation in HD, we have analyzed these cells for the functional expression of surface ligands (L) of the tumor necrosis factor (TNF) superfamily, whose specific receptors are known to transduce proliferation signals at the surface of Hodgkin (H) and Reed-Sternberg (RS) cells.
MATERIALS AND METHODS: Eosinophils from peripheral blood of healthy donors and patients with HD, primary hypereosinophilic syndrome (HES), or secondary hypereosinophilia (HE), were purified by density gradient centrifugation and immunomagnetic depletion of residual granulocytes.
RESULTS: By immunostaining and mRNA analysis, we were able to show that eosinophils from normal donors and patients with HD, HES, and HE express a number of receptors and ligands of the TNF superfamily, including CD40, CD40L, CD30L, CD95/Fas, CD95/FasL and 4-1BB. In addition, we provide evidence that cytokines regulating eosinophil proliferation and activation, i.e., interleukin (IL)-5, IL-3, and granulocyte-macrophage colony-stimulating factor, are able to enhance the cellular density of several TNF superfamily ligands and/or receptors at the surface of cultured eosinophils. Finally, we have shown that native CD40L and CD30L at the surface of purified eosinophils are functionally active and able to transduce proliferative signals on CD40+ and CD30+ target cells, including cultured H-RS cells.
CONCLUSIONS: Our data suggest that eosinophils may act as important elements in the pathology of HD by providing cellular ligands for TNF-superfamily receptors (CD40, CD30, CD95/Fas) able to transduce proliferation and antiapoptotic signals at the surface of H-RS cells. The presence on eosinophils of receptors for TNF ligands expressed by activated T cells (i.e., OX40L, FasL, CD40L, 4-1BBL), also suggest that eosinophils may contribute to the deregulated network of interactive signals between H-RS cells, T cells, and other surrounding reactive cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9209649

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  11 in total

1.  cIAP2 is highly expressed in Hodgkin-Reed-Sternberg cells and inhibits apoptosis by interfering with constitutively active caspase-3.

Authors:  Horst Dürkop; Burkhard Hirsch; Corinna Hahn; Harald Stein
Journal:  J Mol Med (Berl)       Date:  2005-11-25       Impact factor: 4.599

2.  Retrospective analysis of the prognostic role of tissue eosinophil and mast cells in Hodgkin's lymphoma.

Authors:  Katalin Keresztes; Zoltan Szollosi; Zsofia Simon; Ilona Tarkanyi; Zoltan Nemes; Arpad Illes
Journal:  Pathol Oncol Res       Date:  2007-10-07       Impact factor: 3.201

3.  New diagnostic tool for differentiation of idiopathic hypereosinophilic syndrome (HES) and secondary eosinophilic states.

Authors:  T Berki; M Dávid; B Bóné; H Losonczy; J Vass; P Németh
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

4.  Mitral valve destruction by Hodgkin's lymphoma-associated Loefler endocarditis.

Authors:  Sergey Yalonetsky; David Mishaly; Ayelet Ben-Barak; Avraham Lorber
Journal:  Pediatr Cardiol       Date:  2007-11-15       Impact factor: 1.655

5.  Hypereosinophilia in hodgkin lymphoma.

Authors:  Sanju Cyriac; T G Sagar; Rejiv Rajendranath; Krishnakumar Rathnam
Journal:  Indian J Hematol Blood Transfus       Date:  2008-08-24       Impact factor: 0.900

6.  Tumor eosinophil infiltration and improved survival of colorectal cancer patients: Iowa Women's Health Study.

Authors:  Anna E Prizment; Robert A Vierkant; Thomas C Smyrk; Lori S Tillmans; James J Lee; P Sriramarao; Heather H Nelson; Charles F Lynch; Stephen N Thibodeau; Timothy R Church; James R Cerhan; Kristin E Anderson; Paul J Limburg
Journal:  Mod Pathol       Date:  2016-02-26       Impact factor: 7.842

Review 7.  Contribution of Epstein⁻Barr Virus Latent Proteins to the Pathogenesis of Classical Hodgkin Lymphoma.

Authors:  Katerina Vrzalikova; Taofik Sunmonu; Gary Reynolds; Paul Murray
Journal:  Pathogens       Date:  2018-06-27

8.  A Case of Classical Hodgkin's Lymphoma Presenting With Intractable Pruritus.

Authors:  Gregory Benn; Sneha Adidam; Ahmed Ali; Lekidelu Taddesse-Heath
Journal:  Cureus       Date:  2021-11-24

Review 9.  Brentuximab vedotin: clinical updates and practical guidance.

Authors:  Jun Ho Yi; Seok Jin Kim; Won Seog Kim
Journal:  Blood Res       Date:  2017-12-26

Review 10.  Co-Expression of the Epstein-Barr Virus-Encoded Latent Membrane Proteins and the Pathogenesis of Classic Hodgkin Lymphoma.

Authors:  Katerina Vrzalikova; Maha Ibrahim; Eszter Nagy; Martina Vockerodt; Tracey Perry; Wenbin Wei; Ciaran Woodman; Paul Murray
Journal:  Cancers (Basel)       Date:  2018-08-24       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.